Enliven Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Baker Bros. Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 115k | 20.47 |
| 2025-06-30 | $2.3M | 115k | 20.06 |
| 2025-03-31 | $2.3M | 115k | 19.68 |
| 2024-12-31 | $2.6M | 115k | 22.50 |
| 2024-09-30 | $2.9M | 115k | 25.54 |
| 2024-06-30 | $2.7M | 115k | 23.37 |
| 2024-03-31 | $2.0M | 115k | 17.59 |